Alpaqua

Executive Summary

Alpaqua, founded in 2020 and based in Cambridge, MA, specializes in magnet plates for magnetic bead-based separation, a critical tool in life sciences research. Its products are used for nucleic acid extraction and purification, as well as in downstream applications such as PCR/qPCR setup, next-generation sequencing library construction, and target capture protocols. The company also serves protein purification workflows. By enabling efficient and reproducible separation of magnetic beads, Alpaqua's technology supports key laboratory processes in genomics, diagnostics, and drug discovery. The market for magnetic bead-based separation is growing, driven by increasing adoption of NGS and personalized medicine. Alpaqua is well-positioned to capture demand from academic labs, biotech, and pharmaceutical companies. While the company is private and lacks disclosed financials, its niche focus and essential role in lab workflows suggest steady growth potential. Future expansion into high-throughput automation and bioprocessing could further enhance its market position.

Upcoming Catalysts (preview)

• Q3 2026Launch of high-throughput magnetic separation platform70% success
• Q4 2026Strategic partnership with a leading NGS library prep vendor60% success
• 2027Expansion into bioprocessing applications for protein purification50% success